NCT00794248View on ClinicalTrials.gov

Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179)

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

desloratadine 5 mg

Clarinex 5 mg daily x 7 days

DRUG

fexofenadine

Allegra 180 mg daily x 7 days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00794248 - Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179) | Biotech Hunter | Biotech Hunter